The German Bundesrat's health committee discussed the need for changes in noninvasive prenatal testing (NIPT) regulations. The current practice of fetal blood screening for trisomy 13, 18, and 21 under health insurance coverage has raised concerns about unbiased advice and ethical implications. The Senate of Bremen is advocating for common regulations for NIPT and the establishment of an interdisciplinary expert panel to review the legal, ethical, and health policy aspects. Physicians are facing challenges in providing clear indications for the test, leading to potential overuse and inadequate consultation time. Experts emphasize the importance of unbiased consultations to ensure independent decision-making by expecting mothers. The potential societal impact of increased termination rates due to NIPT results is also a significant concern, raising questions about how society supports families with disabled children.
To Another Language
from source content
www.medscape.com
Principais Insights Extraídos De
by Christian Be... às www.medscape.com 06-09-2023
https://www.medscape.com/viewarticle/993006Perguntas Mais Profundas